Reuters Market Eye - Shares in Sun Pharmaceutical Industries Ltd(SUN.NS) rise 2 percent after Swedish drugmaker Meda ABMEDAa.ST said it was not involved in discussions with a potential buyer, contradicting reports that the two companies were in talks.
(To read full story, click here)
Two sources with direct knowledge of the situation had told Reuters on May 31 that Sun Pharmaceutical was in talks to buy Meda for $5 billion to $6 billion.
After those reports, investors had worried Sun would have to assume significant debt to finance the purchase.
(Reporting by Abhishek Vishnoi)
Paytm parent One97 says MediaTek to invest $60 million
MUMBAI Taiwan's largest chip designer MediaTek Inc is investing $60 million in India's One97 Communications, valuing the payment services and e-commerce firm at about $5 billion, the company said on Tuesday.
Wall St falls as Apple drags down tech stocks
U.S. stocks were lower in late morning trading on Tuesday as Apple dragged down technology stocks after EU antitrust regulators ordered the company to pay about $14.5 billion in back taxes to the Irish government.
Google cloud unit close to winning PayPal business - CNBC
Alphabet Inc's Google is close to winning PayPal Holdings Inc as a client for its cloud business, potentially beating out Amazon.com Inc and Microsoft Corp, CNBC reported on Tuesday.